Abstract on the effect of STA363 on disc volume from the phase 1b study has been accepted for oral presentation at a major international congress
Stayble Therapeutics AB ("Stayble" or "the Company") announces that its scientific abstract on the effect of STA363 on disc volume reduction in patients with lumbar disc herniation has been accepted for an oral presentation at the Annual Meeting of the International Society for the Study of the Lumbar Spine (ISSLS) in Atlanta, USA, May 12–16, 2025.The abstract, titled “Intradiscal STA363 in patients with radiculopathy caused by lumbar disc herniation produces volume reduction consistent with symptomatic relief”, presents findings on disc volume reduction following intradiscal injection of